Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SenesTechSNES -1.96%34 EV-to-EBIT is -0.42 as of Sep. 08, 2026. GuruFocus rates SNES with a GF Score™ of 34/100 and a GF Value™ of $0.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,279 Chemicals companies, SenesTech ranks worse than 78186% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
SenesTech's Enterprise Value for the quarter that ended in Jun. 2026 was $5.40 Mil.
SenesTech's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SenesTech EV-to-EBIT Related Terms
SenesTech EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for SenesTech's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, SenesTech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SenesTech EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SenesTech's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where SenesTech's EV-to-EBIT falls into.
SenesTech's current Enterprise Value is $2.98 Mil.
SenesTech's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SenesTech (SNES) has a EV-to-EBIT of -0.42 as of Sep. 08, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on SenesTech and its competitors. According to the industry distribution chart, SenesTech ranks #999999 out of 1279 companies in the Chemicals industry.
Is SenesTech's EV-to-EBIT too high?
SenesTech's current EV-to-EBIT is -0.42. Based on the distribution chart, SenesTech ranks #999999 out of 1279 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, SenesTech has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SenesTech's EV-to-EBIT compare to CNEY and GLGI?
According to the Chemicals industry distribution chart, SenesTech ranks #999999 out of 1279 companies for EV-to-EBIT. This places SenesTech in the lower half of its industry. The industry median EV-to-EBIT is 16.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.73, based on 1,279 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on SenesTech and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SenesTech's current EV-to-EBIT is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SenesTech stock overvalued right now?
Based on GuruFocus' analysis, SenesTech (SNES) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.44, compared to a current price of $1.01 — trading 129.5% above its estimated fair value. The current EV-to-EBIT is -0.42. SenesTech's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For SenesTech (SNES), the current EV-to-EBIT is -0.42 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SenesTech (SNES) Overvalued in 2026?
Based on GuruFocus' analysis, SenesTech stock appears to be overvalued.
The current stock price of $1.01 is trading 129.5% above its estimated GF Value™ of $0.44.
GuruFocus considers SenesTech to be Significantly Overvalued.
Key valuation signals for SNES:
EV-to-EBIT: -0.42
GF Value™: $0.44 vs. price of $1.01 (129.5% above fair value)
No single metric tells the full story. See the SNES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
34GF Score
Get the complete analysis for SNES
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNES has been successfully added to your 
